OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Small-molecule drug repurposing to target DNA damage repair and response pathways
Jacqueline A. Brinkman, Yue Liu, Stephen J. Kron
Seminars in Cancer Biology (2020) Vol. 68, pp. 230-241
Open Access | Times Cited: 36
Jacqueline A. Brinkman, Yue Liu, Stephen J. Kron
Seminars in Cancer Biology (2020) Vol. 68, pp. 230-241
Open Access | Times Cited: 36
Showing 1-25 of 36 citing articles:
Surmounting cancer drug resistance: New insights from the perspective of N6-methyladenosine RNA modification
Bowen Li, Jingwen Jiang, Yehuda G. Assaraf, et al.
Drug Resistance Updates (2020) Vol. 53, pp. 100720-100720
Closed Access | Times Cited: 141
Bowen Li, Jingwen Jiang, Yehuda G. Assaraf, et al.
Drug Resistance Updates (2020) Vol. 53, pp. 100720-100720
Closed Access | Times Cited: 141
Cancer Stem Cells—Key Players in Tumor Relapse
Monica Marzagalli, Fabrizio Fontana, M. Raimondi, et al.
Cancers (2021) Vol. 13, Iss. 3, pp. 376-376
Open Access | Times Cited: 119
Monica Marzagalli, Fabrizio Fontana, M. Raimondi, et al.
Cancers (2021) Vol. 13, Iss. 3, pp. 376-376
Open Access | Times Cited: 119
Biological and pharmacological roles of m6A modifications in cancer drug resistance
Zaoqu Liu, Haijiao Zou, Qin Dang, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 60
Zaoqu Liu, Haijiao Zou, Qin Dang, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 60
Cancer Stem Cells and Their Possible Implications in Cervical Cancer: A Short Review
Riccardo Di Fiore, Sherif Suleiman, Rosa Drago‐Ferrante, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 9, pp. 5167-5167
Open Access | Times Cited: 46
Riccardo Di Fiore, Sherif Suleiman, Rosa Drago‐Ferrante, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 9, pp. 5167-5167
Open Access | Times Cited: 46
Successful Patient-Derived Organoid Culture of Gynecologic Cancers for Disease Modeling and Drug Sensitivity Testing
Jianling Bi, A.M. Newtson, Yuping Zhang, et al.
Cancers (2021) Vol. 13, Iss. 12, pp. 2901-2901
Open Access | Times Cited: 48
Jianling Bi, A.M. Newtson, Yuping Zhang, et al.
Cancers (2021) Vol. 13, Iss. 12, pp. 2901-2901
Open Access | Times Cited: 48
Current understanding of extrachromosomal circular DNA in cancer pathogenesis and therapeutic resistance
Yuanliang Yan, Guijie Guo, Jinzhou Huang, et al.
Journal of Hematology & Oncology (2020) Vol. 13, Iss. 1
Open Access | Times Cited: 50
Yuanliang Yan, Guijie Guo, Jinzhou Huang, et al.
Journal of Hematology & Oncology (2020) Vol. 13, Iss. 1
Open Access | Times Cited: 50
Lessons learned from understanding chemotherapy resistance in epithelial tubo-ovarian carcinoma from BRCA1and BRCA2mutation carriers
Cécile Le Page, Setor Amuzu, Kurosh Rahimi, et al.
Seminars in Cancer Biology (2020) Vol. 77, pp. 110-126
Closed Access | Times Cited: 29
Cécile Le Page, Setor Amuzu, Kurosh Rahimi, et al.
Seminars in Cancer Biology (2020) Vol. 77, pp. 110-126
Closed Access | Times Cited: 29
Prp19/CDC5L promotes gastric cancer via activation of the MAPK pathway-mediated homologous recombination
Shengkui Qiu, Feiran Wang, Xuesong Gao, et al.
International Journal of Biological Sciences (2025) Vol. 21, Iss. 4, pp. 1603-1618
Open Access
Shengkui Qiu, Feiran Wang, Xuesong Gao, et al.
International Journal of Biological Sciences (2025) Vol. 21, Iss. 4, pp. 1603-1618
Open Access
A DNA damage-amplifying nanoagent for cancer treatment via two-way regulation of redox dyshomeostasis and downregulation of tetrahydrofolate
Yi Wang, Zelong Chen, Xingwang An, et al.
International Journal of Biological Macromolecules (2024) Vol. 277, pp. 134276-134276
Closed Access | Times Cited: 3
Yi Wang, Zelong Chen, Xingwang An, et al.
International Journal of Biological Macromolecules (2024) Vol. 277, pp. 134276-134276
Closed Access | Times Cited: 3
Targeting the DNA damage response for patients with lymphoma: Preclinical and clinical evidences
Laura Carrassa, Ilaria Colombo, Giovanna Damia, et al.
Cancer Treatment Reviews (2020) Vol. 90, pp. 102090-102090
Open Access | Times Cited: 23
Laura Carrassa, Ilaria Colombo, Giovanna Damia, et al.
Cancer Treatment Reviews (2020) Vol. 90, pp. 102090-102090
Open Access | Times Cited: 23
The Emerging Roles and Therapeutic Implications of Epigenetic Modifications in Ovarian Cancer
Yu Wang, Zhao Huang, Bowen Li, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 13
Yu Wang, Zhao Huang, Bowen Li, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 13
Potential molecular mechanisms of myrtenal against colon cancer: A systematic review
Lokesh Kumar Boopathy, Anitha Roy, Thiyagarajan Gopal, et al.
Journal of Biochemical and Molecular Toxicology (2023) Vol. 38, Iss. 1
Closed Access | Times Cited: 8
Lokesh Kumar Boopathy, Anitha Roy, Thiyagarajan Gopal, et al.
Journal of Biochemical and Molecular Toxicology (2023) Vol. 38, Iss. 1
Closed Access | Times Cited: 8
Protective role of anticancer drugs in neurodegenerative disorders: A drug repurposing approach
Dia Advani, Rohan Gupta, Rahul Tripathi, et al.
Neurochemistry International (2020) Vol. 140, pp. 104841-104841
Closed Access | Times Cited: 18
Dia Advani, Rohan Gupta, Rahul Tripathi, et al.
Neurochemistry International (2020) Vol. 140, pp. 104841-104841
Closed Access | Times Cited: 18
Small-molecule enhancers of CRISPR-induced homology-directed repair in gene therapy: A medicinal chemist’s perspective
Adrian B.C. Lee, Meng-How Tan, Christina L. L. Chai
Drug Discovery Today (2022) Vol. 27, Iss. 9, pp. 2510-2525
Closed Access | Times Cited: 8
Adrian B.C. Lee, Meng-How Tan, Christina L. L. Chai
Drug Discovery Today (2022) Vol. 27, Iss. 9, pp. 2510-2525
Closed Access | Times Cited: 8
Telomerase Inhibition by MST-312 Sensitizes Breast Cancer Cells to the Anti-cancer Properties of Plumbagin
Safoura Sameni, Ramya Viswanathan, Gavin Yong-Quan Ng, et al.
Genome Integrity (2023) Vol. 14
Open Access | Times Cited: 3
Safoura Sameni, Ramya Viswanathan, Gavin Yong-Quan Ng, et al.
Genome Integrity (2023) Vol. 14
Open Access | Times Cited: 3
A signature of tumor DNA repair genes associated with the prognosis of surgically-resected lung adenocarcinoma
Xiongtao Yang, Guohui Wang, Runchuan Gu, et al.
PeerJ (2020) Vol. 8, pp. e10418-e10418
Open Access | Times Cited: 6
Xiongtao Yang, Guohui Wang, Runchuan Gu, et al.
PeerJ (2020) Vol. 8, pp. e10418-e10418
Open Access | Times Cited: 6
Therapeutic Targeting of Antineoplastic Drugs in Alzheimer’s Disease: Discovered in Repurposed Agents
Mini Dahiya, Anil Kumar, Monu Yadav, et al.
(2023), pp. 329-345
Closed Access | Times Cited: 2
Mini Dahiya, Anil Kumar, Monu Yadav, et al.
(2023), pp. 329-345
Closed Access | Times Cited: 2
Special issue: Drug repurposing for cancer therapy
Sanjay Srivastava
Seminars in Cancer Biology (2020) Vol. 68, pp. 1-2
Closed Access | Times Cited: 3
Sanjay Srivastava
Seminars in Cancer Biology (2020) Vol. 68, pp. 1-2
Closed Access | Times Cited: 3
Telomerase inhibition by MST-312 sensitises breast cancer cells to anti-cancer properties of Plumbagin
Safoura Sameni, Ramya Viswanathan, Gavin Yong-NG Quan, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Safoura Sameni, Ramya Viswanathan, Gavin Yong-NG Quan, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Chromatin-Associated SIN3B Protects Cancer Cells from Genotoxic Stress-Induced Apoptosis and Dictates DNA Damage Repair Pathway Choice
Jorge Morales-Valencia, Coralie Petit, Alexander Calderon, et al.
Molecular Cancer Research (2023) Vol. 21, Iss. 9, pp. 947-957
Open Access | Times Cited: 1
Jorge Morales-Valencia, Coralie Petit, Alexander Calderon, et al.
Molecular Cancer Research (2023) Vol. 21, Iss. 9, pp. 947-957
Open Access | Times Cited: 1
The Role of m6A-Mediated DNA Damage Repair in Tumor Development and Chemoradiotherapy Resistance
Li Qu, Si jian Liu, Ling Zhang, et al.
Cancer Control (2024) Vol. 31
Open Access
Li Qu, Si jian Liu, Ling Zhang, et al.
Cancer Control (2024) Vol. 31
Open Access
Evaluating deposited radiation energy amount and collision quantities of small-molecule radiosensitizers through Monte Carlo simulations
Ghada ALMisned, Ceyda Sibel Kılıç, Asma Almansoori, et al.
Heliyon (2024) Vol. 10, Iss. 13, pp. e33734-e33734
Open Access
Ghada ALMisned, Ceyda Sibel Kılıç, Asma Almansoori, et al.
Heliyon (2024) Vol. 10, Iss. 13, pp. e33734-e33734
Open Access
Unleashing the potential of Genistein and its derivatives as effective therapeutic agents for breast cancer treatment
Eskandar Qaed, Wu Liu, Marwan Almoiliqy, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024)
Closed Access
Eskandar Qaed, Wu Liu, Marwan Almoiliqy, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024)
Closed Access
A Low Dose of Hydrous Icaritin Nano-Formulation with Remarkable Efficacy and Tumor Targeting in Cancer Therapy
Jingxin Fu, Yian Wang, Haowen Li, et al.
Journal of Biomedical Nanotechnology (2021) Vol. 17, Iss. 10, pp. 2003-2013
Closed Access | Times Cited: 3
Jingxin Fu, Yian Wang, Haowen Li, et al.
Journal of Biomedical Nanotechnology (2021) Vol. 17, Iss. 10, pp. 2003-2013
Closed Access | Times Cited: 3
Interplay Between Reactive Oxygen Species and Key Players in the DNA Damage Response Signaling Network
Siddavaram Nagini, P. Thiyagarajan, K. Sridhar Rao
(2022), pp. 1005-1022
Closed Access | Times Cited: 2
Siddavaram Nagini, P. Thiyagarajan, K. Sridhar Rao
(2022), pp. 1005-1022
Closed Access | Times Cited: 2
